FDA Inspection 1328202 — Biomat USA Inc.
The FDA completed an inspection of Biomat USA Inc. on Jul 24, 2026 in Sandy, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 24, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sandy, UT (United States)